Lutetium-(177Lu)-oxodotreotideHypothyroidism

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1984卷 / 1期

关键词：

D O I：

10.1007/s40278-023-50544-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：313 / 313

相关论文

共 50 条

[31] Lutetium-(177Lu)-oxodotreotideHaematological toxicity: case report
Reactions Weekly, 2022, 1892 (1) : 142 - 142
[32] Lutetium-(177Lu)-vipivotide-tetraxetanLack of efficacy
Reactions Weekly, 2024, 2005 (1) : 501 - 501
[33] Lutetium-(177lu)-oxodotreotideHaematotoxicity and hypertension: case report
Reactions Weekly, 2018, 1706 (1) : 321 - 321
[34] Lutetium-(177Lu)-oxodotreotideRenal toxicity: case report
Reactions Weekly, 2021, 1869 (1) : 215 - 215
[35] Lutetium-(177Lu)-oxodotreotideCarcinoid crisis: case report
Reactions Weekly, 2021, 1847 (1) : 285 - 285
[36] Lutetium-(177lu)-oxodotreotideHypoglycaemic crisis: case report
Reactions Weekly, 2022, 1929 (1) : 384 - 384
[37] Lutetium-(177lu)-oxodotreotideHypertensive nephrosclerosis: case report
Reactions Weekly, 2018, 1703 (1) : 168 - 168
[38] Lutetium-(177Lu)-oxodotreotideLiver function test derangements
Reactions Weekly, 2024, 1991 (1) : 134 - 134
[39] Lutetium-(177Lu)-oxodotreotideTachycardia and hypertension: case report
Reactions Weekly, 2019, 1750 (1) : 167 - 167
[40] Denosumab/Lutetium-(177Lu)-oxodotreotide/OctreotideLack of efficacy
Reactions Weekly, 2024, 1998 (1) : 186 - 186

← 1 2 3 4 5 →